LIVN.NASDAQLivanova PLC

Form 4: LivaNova PLC Director Sharon O'Kane Reports Share Transactions

Sentiment:

SEC Form 4


Director Sharon O'Kane reports acquisition and disposal of LivaNova PLC ordinary shares related to restricted stock units.

Summary

  • On June 15, 2024, Sharon O'Kane, a director of LivaNova PLC, reported transactions involving the company's ordinary shares.
  • O'Kane acquired 2,680 ordinary shares through the settlement of restricted stock units (RSUs) at a price of $0.
  • Simultaneously, O'Kane disposed of 1,260 ordinary shares to satisfy tax liabilities at a price of $52.68 per share.
  • Following these transactions, O'Kane directly owns 9,494 ordinary shares.
  • Additionally, O'Kane was granted 3,416 RSUs that vest on June 15, 2025, subject to continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the transactions are routine and related to executive compensation. There are no indications of significant positive or negative implications for the company.

Positives

  • The acquisition of shares through RSU settlement indicates confidence in the company's future performance.

Negatives

  • The disposal of shares to cover tax liabilities, while routine, slightly reduces the director's holdings.

Risks

  • Future vesting of RSUs is contingent on continued service, creating a potential risk if the director leaves the company before the vesting date.

Future Outlook

The director's future holdings will be affected by the vesting of the 3,416 RSUs in June 2025, contingent on continued service.

Industry Context

This filing is a routine disclosure related to executive compensation and share ownership, common in publicly traded companies. It provides transparency to investors regarding the alignment of management's interests with those of shareholders.

Comparison to Industry Standards

  • Executive compensation packages including RSUs are standard practice among publicly traded companies like LivaNova PLC.
  • Companies such as Medtronic and Boston Scientific also utilize RSUs as part of their executive compensation plans.
  • The vesting schedules and terms of these RSUs are generally aligned with industry norms to incentivize long-term performance and retention.

Stakeholder Impact

  • The transactions provide transparency to shareholders regarding executive compensation and share ownership.
  • The vesting of RSUs incentivizes the director to contribute to the company's long-term success, benefiting shareholders.

Key Dates

DateDescription
June 15, 2023Reporting person was granted RSUs vesting on June 15, 2024.
June 15, 2024Date of transactions: acquisition of 2,680 shares via RSU settlement and disposal of 1,260 shares for tax liability.
June 15, 2025Vesting date for 3,416 newly granted RSUs.
June 18, 2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.